WASHINGTON - An advisory panel for the U.S. Centers for Disease Control and Prevention granted its final approval on Thursday for offering booster doses of Pfizer’s COVID-19 vaccine to Americans ages 65 and up and others at high risk for severe disease, clearing the way for the extra shots to begin.
The advisory panel to the CDC recommended the extra doses for people 65 and older, nursing home residents, and people who are 50 to 64 with underlying medical conditions.
It also said boosters can be offered to people 18 to 49 with underlying conditions.The shots would be given at least six months after the second dose of the Pfizer vaccine.CDC Director Dr.